Nanobiotix S.A. (NBTX) Financials

NBTX Assets vs Liabilities

DateAssetsLiabilities
2023-06-30 43.9 million 102.4 million
2023-03-31 65.1 million 94.6 million
2022-12-31 64.1 million 93.2 million
2022-09-30 58.6 million 85.1 million

NBTX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-06-30 -9.6 million 733407
2023-03-31 -22.0 million 988636
2022-12-31 ? ?
2022-09-30 -9.6 million 889604

NBTX Net Income

No data available :(

NBTX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-06-30 23.5 million - 5.7 million
2023-03-31 45.1 million - -
2022-12-31 44.4 million - 5.9 million
2022-09-30 40.6 million - -

NBTX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-06-30 38.1 million
2023-03-31 38.0 million
2022-12-31 37.4 million
2022-09-30 34.2 million

NBTX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-06-30 175604 9.7 million - -
2023-03-31 15260 16.9 million - -
2022-12-31 6975 - - -
2022-09-30 6375 7.9 million - -

NBTX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-06-30 1.8 million -
2023-03-31 1.9 million 821865
2022-12-31 - -
2022-09-30 1.7 million -

NBTX

Price: $6.60

52 week price:
1.75
11.00

Earnings Per Share: -1.82 USD

P/E Ratio: -3.96

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 700

Market Capitalization: 310.5 million

Links: